pcDNA3.1-ccdB-Nanoluc Citations (12)
Originally described in: Taipale Lab plasmidsUnpublished
Articles Citing pcDNA3.1-ccdB-Nanoluc
Articles |
---|
Slc7a5 regulates Kv1.2 channels and modifies functional outcomes of epilepsy-linked channel mutations. Baronas VA, Yang RY, Morales LC, Sipione S, Kurata HT. Nat Commun. 2018 Oct 24;9(1):4417. doi: 10.1038/s41467-018-06859-x. PubMed |
Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. Hennigan RF, Fletcher JS, Guard S, Ratner N. Sci Signal. 2019 Apr 23;12(578):eaau8749. doi: 10.1126/scisignal.aau8749. PubMed |
YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis. Li J, Yao M, Zhu X, Li Q, He J, Chen L, Wang W, Zhu C, Shen T, Cao R, Fang C. J Dent Res. 2019 Jul;98(8):920-929. doi: 10.1177/0022034519851804. PubMed |
A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. McFall T, Diedrich JK, Mengistu M, Littlechild SL, Paskvan KV, Sisk-Hackworth L, Moresco JJ, Shaw AS, Stites EC. Sci Signal. 2019 Sep 24;12(600). pii: 12/600/eaaw8288. doi: 10.1126/scisignal.aaw8288. PubMed |
Control of Slc7a5 sensitivity by the voltage-sensing domain of Kv1 channels. Lamothe SM, Sharmin N, Silver G, Satou M, Hao Y, Tateno T, Baronas VA, Kurata HT. Elife. 2020 Nov 9;9. pii: 54916. doi: 10.7554/eLife.54916. PubMed |
GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo. Arcones AC, Vila-Bedmar R, Mirasierra M, Cruces-Sande M, Vallejo M, Jones B, Tomas A, Mayor F Jr, Murga C. BMC Biol. 2021 Mar 3;19(1):40. doi: 10.1186/s12915-021-00966-w. PubMed |
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1. Marzook A, Chen S, Pickford P, Lucey M, Wang Y, Correa IR Jr, Broichhagen J, Hodson DJ, Salem V, Rutter GA, Tan TM, Bloom SR, Tomas A, Jones B. Biochem Pharmacol. 2021 Aug;190:114656. doi: 10.1016/j.bcp.2021.114656. Epub 2021 Jun 12. PubMed |
Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking. Lucey M, Ashik T, Marzook A, Wang Y, Goulding J, Oishi A, Broichhagen J, Hodson DJ, Minnion J, Elani Y, Jockers R, Briddon SJ, Bloom SR, Tomas A, Jones B. Mol Pharmacol. 2021 Jul 27. pii: molpharm.121.000270. doi: 10.1124/molpharm.121.000270. PubMed |
Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach. McFall T, Stites EC. Cell Rep. 2021 Dec 14;37(11):110096. doi: 10.1016/j.celrep.2021.110096. PubMed |
Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening. Hegazy L, Gill LE, Pyles KD, Kaiho C, Kchouk S, Finck BN, McCommis KS, Elgendy B. Biomedicines. 2022 Feb 2;10(2). pii: biomedicines10020365. doi: 10.3390/biomedicines10020365. PubMed |
Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells. Manchanda Y, Bitsi S, Chen S, Broichhagen J, Bernardino de la Serna J, Jones B, Tomas A. Endocrinology. 2023 Mar 13;164(5):bqad028. doi: 10.1210/endocr/bqad028. PubMed |
Merlin tumor suppressor function is regulated by PIP2-mediated dimerization. Hennigan RF, Thomson CS, Stachowski K, Nassar N, Ratner N. PLoS One. 2023 Feb 21;18(2):e0281876. doi: 10.1371/journal.pone.0281876. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.